Novant Health Clinical Research provides access to a variety of vascular research studies.
Study Name/Number: PFO ACCESS Registry
Title: Closure of Patent Foramen Ovale with the Amplatzer PFO Occluder-PFO ACCESS Registry
Investigator: Michael Drucker, MD
Purpose: The purpose of this study is to allow access to the AMPLATZER PFO Occluder in subjects with a PFO who have already experienced at least two cryptogenic strokes due to presumed paradoxical embolism through a patent foramen ovale and who have failed conventional drug therapy.
Eligibility: Patients with documented PFO and recurrent cryptogenic stroke on anticoagulant or antiplatelet therapy
Link to the current ClinicalTrials.gov record »